CRISPR immunity: a case study for justified somatic genetic modification?
Eli Y Adashi1, Ivan Glenn Cohen2
1Medical Science, Brown University, Providence, Rhode Island, USA eli_adashi@brown.edu.
Abstract:
The current SARS-CoV-2 pandemic has killed thousands across the world. SARS-CoV-2 is the latest but surely not the last such global pandemic we will face. The biomedical response to such pandemics includes treatment, vaccination, and so on. In this paper, though, we argue that it is time to consider an additional strategy: the somatic (non-heritable) enhancement of human immunity. We argue for this approach and consider bioethics objections we believe can be overcome.
Related Concept Videos
CRISPR
CRISPR/Cas9 Genome Editing
What is Genetic Engineering?
Homologous Recombination
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...


